Pharmacogenomics of multiple sclerosis: Association of immune response gene polymorphisms with copaxone treatment efficacy

2011 ◽  
Vol 45 (6) ◽  
pp. 886-893 ◽  
Author(s):  
E. Yu. Tsareva ◽  
O. G. Kulakova ◽  
O. Yu. Makarycheva ◽  
A. N. Boyko ◽  
S. G. Shchur ◽  
...  
2015 ◽  
Vol 62 (4) ◽  
pp. 633-640 ◽  
Author(s):  
Marek Fol ◽  
Magdalena Druszczynska ◽  
Marcin Wlodarczyk ◽  
Elzbieta Ograczyk ◽  
Wieslawa Rudnicka

2005 ◽  
Vol 80 (12) ◽  
pp. 1773-1782 ◽  
Author(s):  
Svetlana Dmitrienko ◽  
David I. Hoar ◽  
Robert Balshaw ◽  
Paul A. Keown

Blood ◽  
2017 ◽  
Vol 129 (4) ◽  
pp. 525-532 ◽  
Author(s):  
Renato Cunha ◽  
Marco A. Zago ◽  
Sergio Querol ◽  
Fernanda Volt ◽  
Annalisa Ruggeri ◽  
...  

Key Points Gene polymorphism of the immune response as CTLA4 was shown to impact CBT outcomes according to CBU genotype. CTLA4-CBU genotype might be considered for CBU selection when >1 CBU meeting the current suggested selection criteria is available.


2010 ◽  
Vol 9 (1) ◽  
pp. 58-68 ◽  
Author(s):  
A. Maver ◽  
I. Medica ◽  
B. Salobir ◽  
M. Tercelj ◽  
B. Peterlin

Nature ◽  
1982 ◽  
Vol 295 (5847) ◽  
pp. 329-331 ◽  
Author(s):  
Leonore A. Herzenberg ◽  
Takeshi Tokuhisa ◽  
Kyoko Hayakawa ◽  
Leonard A. Herzenberg

2006 ◽  
Vol 12 (7-8) ◽  
pp. 185-195 ◽  
Author(s):  
Kevin McLoughlin ◽  
Ken Turteltaub ◽  
Danute Bankaitis-Davis ◽  
Richard Gerren ◽  
Lisa Siconolfi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document